Phenominer Database Results (50 results)

 

How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Time Value Clinical Measurement Notes Record ID Study ID
SS.ZUC-Leprfa-/-/Slc heart weight to tibia length ratio atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart mass male 91 days 13 0.42 g/cm 0.01 0.04 post excision weight measurement 0.0 0 101975 2644
SS.ZUC-Leprfa-/-/Slc epididymal fat pad weight to tibia length ratio atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. epididymal fat pad mass male 91 days 13 3.58 g/cm 0.12 0.42 post excision weight measurement 0.0 0 ef/tl 101984 2644
SS.ZUC-Leprfa-/-/Slc mesenteric fat pad weight to tibia length ratio atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. mesenteric fat pad mass male 91 days 13 348.17 mg/mm 9.57 34.51 post excision weight measurement 0.0 0 mf/tl, mesenteric fat pad weight to tibia length ratio 101988 2644
SS.ZUC-Leprfa-/-/Slc heart ventricle septal wall thickness atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart left ventricle wall thickness male 91 days 13 0.2 cm 0.0 0.01 echocardiography 0.0 0 101994 2644
SS.ZUC-Leprfa-/-/Slc heart left ventricle end-diastolic diameter atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart left ventricle end-diastolic diameter male 91 days 13 8.56 mm 0.08 0.29 echocardiography 0.0 0 101996 2644
SS.ZUC-Leprfa-/-/Slc E wave deceleration time atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. blood flow trait male 91 days 13 46.93 ms 1.06 3.82 echocardiography 0.0 0 102014 2644
SS.ZUC-Leprfa-/-/Slc E wave deceleration time atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. blood flow trait male 91 days 13 43.5 ms 1.57 5.66 echocardiography 0.0 0 102015 2644
SS.ZUC-Leprfa-/-/Slc heart isovolumetric relaxation time atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart muscle relaxation trait male 91 days 13 29.2 ms 1.79 6.45 echocardiography 0.0 0 102018 2644
SS.ZUC-Leprfa-/-/Slc tibia straight segment length atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. tibia length male 91 days 13 34.58 mm 0.15 0.54 body measuring method 0.0 0 101972 2644
SS.ZUC-Leprfa-/-/Slc heart weight to tibia length ratio atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart mass male 91 days 13 0.43 g/cm 0.01 0.04 post excision weight measurement 0.0 0 101976 2644
SS.ZUC-Leprfa-/-/Slc heart left ventricle weight to tibia length ratio atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart left ventricle mass male 91 days 13 0.3 g/cm 0.01 0.03 post excision weight measurement 0.0 0 lv/tl 101978 2644
SS.ZUC-Leprfa-/-/Slc epididymal fat pad weight to tibia length ratio atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. epididymal fat pad mass male 91 days 13 3.62 g/cm 0.09 0.34 post excision weight measurement 0.0 0 ef/tl 101985 2644
SS.ZUC-Leprfa-/-/Slc serum total cholesterol level atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. blood cholesterol amount male 91 days 7 218.0 mg/dl 26.0 68.79 serum total cholesterol measurement test 0.0 0 101942 2644
SS.ZUC-Leprfa-/-/Slc serum total cholesterol level atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. blood cholesterol amount male 91 days 7 200.33 mg/dl 44.7 118.27 serum total cholesterol measurement test 0.0 0 101943 2644
SS.ZUC-Leprfa-/-/Slc serum free fatty acids level atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. blood free fatty acid amount male 91 days 7 0.61 mmol/l 0.05 0.13 serum free fatty acid analysis 0.0 0 101954 2644
SS.ZUC-Leprfa-/-/Slc serum glucose level atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. blood glucose amount male 91 days 7 143.0 mg/dl 14.78 39.1 serum glucose analysis 0.0 0 101957 2644
SS.ZUC-Leprfa-/-/Slc serum insulin level atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. blood insulin amount male 91 days 7 0.0 mg/dl 0.0 0.0 serum insulin analysis 0.0 0 101960 2644
SS.ZUC-Leprfa-/-/Slc serum insulin level atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. blood insulin amount male 91 days 7 0.0 mg/dl 0.0 0.0 serum insulin analysis 0.0 0 101961 2644
SS.ZUC-Leprfa-/-/Slc heart left ventricle relative wall thickness atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart left ventricle wall thickness male 91 days 13 46.0 % 1.0 3.61 echocardiography 0.0 0 102005 2644
SS.ZUC-Leprfa-/-/Slc heart left ventricle relative wall thickness atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart left ventricle wall thickness male 91 days 13 47.0 % 2.0 7.21 echocardiography 0.0 0 102006 2644
SS.ZUC-Leprfa-/-/Slc ejection fraction atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. cardiac output trait male 91 days 13 79.33 % 1.21 4.36 echocardiography 0.0 0 102011 2644
SS.ZUC-Leprfa-/-/Slc heart left ventricular end-diastolic blood pressure to heart left ventricular end-diastolic diameter ratio atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart left ventricular blood pressure trait male 91 days 13 1.2 mmHg/mm 0.25 0.9 vascular transducer tipped catheter 0.0 0 102026 2644
SS.ZUC-Leprfa-/-/Slc mesenteric fat pad weight to tibia length ratio atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. mesenteric fat pad mass male 91 days 13 371.46 mg/mm 9.6 34.61 post excision weight measurement 0.0 0 mf/tl 101987 2644
SS.ZUC-Leprfa-/-/Slc heart ventricle septal wall thickness atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart left ventricle wall thickness male 91 days 13 0.2 cm 0.0 0.01 echocardiography 0.0 0 101993 2644
SS.ZUC-Leprfa-/-/Slc inguinal fat pad weight to tibia length ratio atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. inguinal fat pad mass male 91 days 13 1482.16 mg/mm 53.88 194.27 post excision weight measurement 0.0 0 if/tl 101991 2644
SS.ZUC-Leprfa-/-/Slc serum low density lipoprotein cholesterol level atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. blood LDL cholesterol amount male 91 days 7 66.0 mg/dl 9.1 24.08 serum low-density lipoprotein-cholesterol measurement test 0.0 0 101945 2644
SS.ZUC-Leprfa-/-/Slc serum glucose level atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. blood glucose amount male 91 days 7 154.33 mg/dl 15.15 40.08 serum glucose analysis 0.0 0 101958 2644
SS.ZUC-Leprfa-/-/Slc time constant of left ventricular pressure decay atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart left ventricular blood pressure trait male 91 days 13 25.89 ms 1.53 5.52 echocardiography 0.0 0 102020 2644
SS.ZUC-Leprfa-/-/Slc heart left ventricular end-diastolic blood pressure to heart left ventricular end-diastolic diameter ratio atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart left ventricular blood pressure trait male 91 days 13 1.05 mmHg/mm 0.24 0.87 vascular transducer tipped catheter 0.0 0 102027 2644
SS.ZUC-Leprfa-/-/Slc inguinal fat pad weight to tibia length ratio atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. inguinal fat pad mass male 91 days 13 1448.07 mg/mm 60.58 218.42 post excision weight measurement 0.0 0 if/tl 101990 2644
SS.ZUC-Leprfa-/-/Slc tibia straight segment length atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. tibia length male 91 days 13 34.52 mm 0.21 0.76 body measuring method 0.0 0 101973 2644
SS.ZUC-Leprfa-/-/Slc retroperitoneal fat pad weight to tibia length ratio atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. retroperitoneal fat pad mass male 91 days 13 415.13 mg/mm 12.15 43.81 post excision weight measurement 0.0 0 rf/tl 101981 2644
SS.ZUC-Leprfa-/-/Slc retroperitoneal fat pad weight to tibia length ratio atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. retroperitoneal fat pad mass male 91 days 13 429.58 mg/mm 14.03 50.59 post excision weight measurement 0.0 0 rf/tl 101982 2644
SS.ZUC-Leprfa-/-/Slc serum high density lipoprotein cholesterol level atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. blood HDL cholesterol amount male 91 days 7 99.71 mg/dl 5.83 15.42 serum high-density lipoprotein-cholesterol measurement test 0.0 0 101949 2644
SS.ZUC-Leprfa-/-/Slc heart posterior wall thickness atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart left ventricle posterior wall thickness male 91 days 13 0.2 cm 0.0 0.01 echocardiography 0.0 0 101999 2644
SS.ZUC-Leprfa-/-/Slc heart left ventricle fractional shortening atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart left ventricle end-diastolic diameter male 91 days 13 44.28 % 1.6 5.77 echocardiography 0.0 0 102009 2644
SS.ZUC-Leprfa-/-/Slc ejection fraction atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. cardiac output trait male 91 days 13 79.88 % 1.51 5.44 echocardiography 0.0 0 102012 2644
SS.ZUC-Leprfa-/-/Slc heart isovolumetric relaxation time atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart muscle relaxation trait male 91 days 13 32.78 ms 1.14 4.11 echocardiography 0.0 0 102017 2644
SS.ZUC-Leprfa-/-/Slc left ventricular end-diastolic blood pressure atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart left ventricular blood pressure trait male 91 days 13 10.39 mmHg 2.03 7.32 vascular transducer tipped catheter 0.0 0 102023 2644
SS.ZUC-Leprfa-/-/Slc heart left ventricle weight to tibia length ratio atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart left ventricle mass male 91 days 13 0.31 g/cm 0.01 0.03 post excision weight measurement 0.0 0 lv/tl 101979 2644
SS.ZUC-Leprfa-/-/Slc serum low density lipoprotein cholesterol level atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. blood LDL cholesterol amount male 91 days 7 57.25 mg/dl 13.15 34.79 serum low-density lipoprotein-cholesterol measurement test 0.0 0 101946 2644
SS.ZUC-Leprfa-/-/Slc serum high density lipoprotein cholesterol level atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. blood HDL cholesterol amount male 91 days 7 94.83 mg/dl 6.35 16.8 serum high-density lipoprotein-cholesterol measurement test 0.0 0 101948 2644
SS.ZUC-Leprfa-/-/Slc serum triglyceride level atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. blood triglyceride amount male 91 days 7 1190.0 mg/dl 324.22 857.81 serum triglyceride analysis 0.0 0 101951 2644
SS.ZUC-Leprfa-/-/Slc serum triglyceride level atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. blood triglyceride amount male 91 days 7 980.67 mg/dl 302.75 801.0 serum triglyceride analysis 0.0 0 101952 2644
SS.ZUC-Leprfa-/-/Slc serum free fatty acids level atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. blood free fatty acid amount male 91 days 7 0.59 mmol/l 0.03 0.08 serum free fatty acid analysis 0.0 0 101955 2644
SS.ZUC-Leprfa-/-/Slc heart left ventricle end-diastolic diameter atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart left ventricle end-diastolic diameter male 91 days 13 8.43 mm 0.11 0.4 echocardiography 0.0 0 101997 2644
SS.ZUC-Leprfa-/-/Slc heart posterior wall thickness atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart left ventricle posterior wall thickness male 91 days 13 0.2 cm 0.01 0.02 echocardiography 0.0 0 102000 2644
SS.ZUC-Leprfa-/-/Slc left ventricular end-diastolic blood pressure atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart left ventricular blood pressure trait male 91 days 13 8.77 mmHg 1.87 6.74 vascular transducer tipped catheter 0.0 0 102024 2644
SS.ZUC-Leprfa-/-/Slc heart left ventricle fractional shortening atorvastatin (6 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart left ventricle end-diastolic diameter male 91 days 13 43.53 % 1.18 4.25 echocardiography 0.0 0 102008 2644
SS.ZUC-Leprfa-/-/Slc time constant of left ventricular pressure decay atorvastatin (20 mg/kg/d) (for 28 days) Yamada Y, et al., Int J Cardiol. 2017 Aug 1;240:332-338. doi: 10.1016/j.ijcard.2017.04.103. Epub 2017 May 4. heart left ventricular blood pressure trait male 91 days 13 22.53 ms 0.89 3.21 echocardiography 0.0 0 102021 2644